Biochimica et Biophysica Acta 2015-09-01

Epilepsy-causing mutations in Kv7.2 C-terminus affect binding and functional modulation by calmodulin.

Paolo Ambrosino, Alessandro Alaimo, Silvia Bartollino, Laura Manocchio, Michela De Maria, Ilaria Mosca, Carolina Gomis-Perez, Araitz Alberdi, Giovanni Scambia, Gaetan Lesca, Alvaro Villarroel, Maurizio Taglialatela, Maria Virginia Soldovieri

Index: Biochim. Biophys. Acta 1852 , 1856-66, (2015)

Full Text: HTML

Abstract

Mutations in the KCNQ2 gene, encoding for voltage-gated Kv7.2K(+) channel subunits, are responsible for early-onset epileptic diseases with widely-diverging phenotypic presentation, ranging from Benign Familial Neonatal Seizures (BFNS) to epileptic encephalopathy. In the present study, Kv7.2 BFNS-causing mutations (W344R, L351F, L351V, Y362C, and R553Q) have been investigated for their ability to interfere with calmodulin (CaM) binding and CaM-induced channel regulation. To this aim, semi-quantitative (Far-Western blotting) and quantitative (Surface Plasmon Resonance and dansylated CaM fluorescence) biochemical assays have been performed to investigate the interaction of CaM with wild-type or mutant Kv7.2 C-terminal fragments encompassing the CaM-binding domain; in parallel, mutation-induced changes in CaM-dependent Kv7.2 or Kv7.2/Kv7.3 current regulation were investigated by patch-clamp recordings in Chinese Hamster Ovary (CHO) cells co-expressing Kv7.2 or Kv7.2/Kv7.3 channels and CaM or CaM1234 (a CaM isoform unable to bind Ca(2+)). The results obtained suggest that each BFNS-causing mutation prompts specific biochemical and/or functional consequences; these range from slight alterations in CaM affinity which did not translate into functional changes (L351V), to a significant reduction in the affinity and functional modulation by CaM (L351F, Y362C or R553Q), to a complete functional loss without significant alteration in CaM affinity (W344R). CaM overexpression increased Kv7.2 and Kv7.2/Kv7.3 current levels, and partially (R553Q) or fully (L351F) restored normal channel function, providing a rationale pathogenetic mechanism for mutation-induced channel dysfunction in BFNS, and highlighting the potentiation of CaM-dependent Kv7.2 modulation as a potential therapeutic approach for Kv7.2-related epilepsies. Copyright © 2015 Elsevier B.V. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
Sodium Fluoride Structure Sodium Fluoride
CAS:7681-49-4
Guanidine hydrochloride Structure Guanidine hydrochloride
CAS:50-01-1
sodium chloride Structure sodium chloride
CAS:7647-14-5
HEPES Structure HEPES
CAS:7365-45-9
SODIUM CHLORIDE-35 CL Structure SODIUM CHLORIDE-35 CL
CAS:20510-55-8
Glycerol Structure Glycerol
CAS:56-81-5
Glutathione Structure Glutathione
CAS:70-18-8
DL-Dithiothreitol Structure DL-Dithiothreitol
CAS:3483-12-3
Ethylenediaminetetraacetic acid Structure Ethylenediaminetetraacetic acid
CAS:60-00-4